Understanding the Pharmacological Differences: Why is TNK Better Than tPA?
•
4 min read
Recent clinical trials and meta-analyses suggest that tenecteplase (TNK) offers significant clinical and practical advantages over alteplase (tPA) for treating acute ischemic stroke and myocardial infarction. The core differences lie in their molecular structure, addressing the critical question: why is TNK better than tPA?
